1. Home
  2. GLRE vs BVS Comparison

GLRE vs BVS Comparison

Compare GLRE & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenlight Capital Re Ltd.

GLRE

Greenlight Capital Re Ltd.

HOLD

Current Price

$18.12

Market Cap

481.5M

Sector

Finance

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$10.32

Market Cap

617.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLRE
BVS
Founded
2004
2011
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.5M
617.1M
IPO Year
2007
2016

Fundamental Metrics

Financial Performance
Metric
GLRE
BVS
Price
$18.12
$10.32
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$14.00
AVG Volume (30 Days)
243.1K
416.1K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
75.00
163.46
EPS
2.17
0.33
Revenue
$729,777,000.00
$568,087,000.00
Revenue This Year
N/A
$7.52
Revenue Next Year
N/A
$7.06
P/E Ratio
$8.35
$29.97
Revenue Growth
4.85
N/A
52 Week Low
$11.57
$5.81
52 Week High
$18.99
$9.98

Technical Indicators

Market Signals
Indicator
GLRE
BVS
Relative Strength Index (RSI) 63.65 72.84
Support Level $12.66 $8.43
Resistance Level N/A N/A
Average True Range (ATR) 0.57 0.36
MACD -0.04 0.10
Stochastic Oscillator 58.54 87.83

Price Performance

Historical Comparison
GLRE
BVS

About GLRE Greenlight Capital Re Ltd.

Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: